EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

The efficacy of lamotrigine in bipolar disorder: A systematic review and meta‐analysis

N Haenen, A M Kamperman iD, A Prodan, W A Nolen, M P Boks, R Wesseloo iD

Bipolar Disorders · 2024-08 · 26 (5) · 431-441

DOI: 10.1111/bdi.13452 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Bipolar Disorders, online erschienen am 15.05.2024. Verfasst von N Haenen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Erasmus University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Lamotrigine, Bipolar Disorder, Triazines. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To provide up‐to‐date clinical guidance on the efficacy of lamotrigine in bipolar disorder (BD).

Methods

Eligible studies were identified during a systematic literature search according to PRISMA‐guidelines. We included randomized controlled trials (RCTs) and cohort studies that quantitatively assessed lamotrigine's efficacy in BD. We divided the included studies into three groups: 1. acute treatment of depression, 2. acute treatment of mania and hypomania, and 3. maintenance treatment. Analyses were stratified by control group (placebo vs active comparator) and treatment strategy (monotherapy vs add‐on treatment).

Results

We included 20 RCTs ( n = 1166 lamotrigine users) and 20 cohort studies ( n = 11,141 lamotrigine users). Twenty‐four of these studies were included in meta‐analyses. During depressive episodes, greater decreases in depressive symptomatology were associated with initiation of lamotrigine as add‐on treatment than with placebo (SMD −0.30 [95% CI = −0.51, −0.10], df = 3, p = 0.004). Decreases in depressive symptomatology did not differ significantly between lamotrigine and the active comparator (SMD −0.28 [95% CI = −1.06, 0.50], df = 3, p = 0.488). As a maintenance treatment, lamotrigine was associated with a significantly lower relapse/recurrence rate than placebo (risk ratio (RR) 0.84 [95% CI = 0.71, 0.99], df = 2, p = 0.037). Relapse/recurrence rates did not differ significantly between lamotrigine and lithium (RR 1.06 [95% CI = 0.89, 1.25], df = 2, p = 0.513). A qualitative assessment of high‐quality register‐based studies found that lamotrigine was associated with lower hospital admission rates than other commonly used treatment regimes.

Conclusions

There is substantial evidence for the efficacy of lamotrigine in BD, specifically as add‐on treatment during acute depressive episodes and as maintenance treatment for preventing relapse and recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LamotrigineBipolar DisorderTriazinesHumansAntimanic AgentsRandomized Controlled Trials as TopicTreatment OutcomeAnticonvulsants

Stichwörter der Autor:innen

bipolar disorderefficacylamotrigine

Substanzen

LamotrigineTriazinesAntimanic AgentsAnticonvulsants

Autor:innen und Institutionen

  • Department of Psychiatry, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • The Netherlands Institute for Forensic Psychiatry and Psychology (NIFP), Penitentiary Psychiatric Centre (PPC), Vught, the Netherlands.
  • Department of Psychiatry, Epidemiological and Social Psychiatric Research Institute (ESPRi), Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center, Utrecht, the Netherlands.
  • Department of Psychiatry, University Medical Center Groningen, Groningen, the Netherlands.
  • Bipolar Disorder Expert Team, GGZ Delfland, Delft, the Netherlands.

ORCID-Profile: A M Kamperman, R Wesseloo

Zitieren

APA

Haenen, N., Kamperman, A. M., Prodan, A., Nolen, W. A., Boks, M. P., & Wesseloo, R. (2024). The efficacy of lamotrigine in bipolar disorder: A systematic review and meta‐analysis. Bipolar Disorders, 26(5), 431-441. https://doi.org/10.1111/bdi.13452

Vancouver

Haenen N, Kamperman AM, Prodan A, Nolen WA, Boks MP, Wesseloo R. The efficacy of lamotrigine in bipolar disorder: A systematic review and meta‐analysis. Bipolar Disorders. 2024;26(5):431-441. doi:10.1111/bdi.13452

BibTeX
@article{Haenen2024,
  author = {Haenen, N and Kamperman, A M and Prodan, A and Nolen, W A and Boks, M P and Wesseloo, R},
  title = {The efficacy of lamotrigine in bipolar disorder: A systematic review and meta‐analysis},
  journal = {Bipolar Disorders},
  year = {2024},
  volume = {26},
  number = {5},
  pages = {431--441},
  doi = {10.1111/bdi.13452}
}
Kostenlos starten →